Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Current HIV Research
|
January 24, 2012
Non-specific microbicide product development: then and now
Joseph W Romano, Melissa Robbiani, Gustavo F Doncel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 25, 2010
Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety vs. Hydroxyethyl cellulose-based universal placebo gel
Annalene M Nel, Shanique C Smythe, Sepideh Habibi, et al.
Expert Opinion on Drug Delivery
|
December 27, 2021
Drug-releasing vaginal rings for HIV/STI and pregnancy prevention: a review of recent advances and clinical applications
Thesla Palanee-Phillips, Marc M Baum, John A Moss, et al.
Antimicrobial Agents and Chemotherapy
|
December 19, 2007
Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days
Jeremy P Nuttall, Daryl C Thake, Mark G Lewis, et al.
Protein Expression and Purification
|
January 12, 2005
Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development
Diana M Colleluori, Deborah Tien, Feirong Kang, et al.
AIDS Research and Human Retroviruses
|
October 18, 2005
In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials
Deborah Tien, Roger L Schnaare, Feirong Kang, et al.
Spine
|
July 22, 2022
Outcomes Following Direct Versus Indirect Decompression Techniques for Lumbar Spondylolisthesis: A Propensity-Matched Analysis
Lydia J McKeithan, Joseph W Romano, William H Waddell, et al.
AIDS Research and Human Retroviruses
|
April 29, 2021
Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting
Joseph W Romano, Marc M Baum, Zach R Demkovich, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Current HIV Research
|
January 24, 2012
Non-specific microbicide product development: then and now
Joseph W Romano, Melissa Robbiani, Gustavo F Doncel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 25, 2010
Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety vs. Hydroxyethyl cellulose-based universal placebo gel
Annalene M Nel, Shanique C Smythe, Sepideh Habibi, et al.
Expert Opinion on Drug Delivery
|
December 27, 2021
Drug-releasing vaginal rings for HIV/STI and pregnancy prevention: a review of recent advances and clinical applications
Thesla Palanee-Phillips, Marc M Baum, John A Moss, et al.
Antimicrobial Agents and Chemotherapy
|
December 19, 2007
Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days
Jeremy P Nuttall, Daryl C Thake, Mark G Lewis, et al.
Protein Expression and Purification
|
January 12, 2005
Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development
Diana M Colleluori, Deborah Tien, Feirong Kang, et al.
AIDS Research and Human Retroviruses
|
October 18, 2005
In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials
Deborah Tien, Roger L Schnaare, Feirong Kang, et al.
Spine
|
July 22, 2022
Outcomes Following Direct Versus Indirect Decompression Techniques for Lumbar Spondylolisthesis: A Propensity-Matched Analysis
Lydia J McKeithan, Joseph W Romano, William H Waddell, et al.
AIDS Research and Human Retroviruses
|
April 29, 2021
Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting
Joseph W Romano, Marc M Baum, Zach R Demkovich, et al.
Page
of 1